PSTV Rentabilitas operasi Plus Therapeutics Inc

Asset volatility for Plus Therapeutics, Inc. (PSTV) is driven by the development of radiotherapy to combat breast and brain tumors. The operating margin curve on the GURU.Markets platform chart shows that the current metric is -364.40. While insurance payments for high-tech treatment provide stability, the lack of recurring revenue due to early-stage drug trials creates typical biotech risks.
Plus Therapeutics Inc - rincian analitis lan metrik utama (PSTV)
- kuotasi lan prakiraan analis:
- data kapitalisasi pasar:
- rincian nilai buku perusahaan:
- data utang lan likuiditas:
Total Utang marang Modal Plus Therapeutics, Inc.|PSTV - Koefisien utang jangka dawa marang modal|Utang jangka cendhak marang modal Plus Therapeutics Inc|PSTV - Utang kumulatif perusahaan|Rasio utang marang kapitalisasi buku Cytori Therapeutics|PSTV - Silihan lan utang jangka dawa perusahaan|Utang jangka cendhak perusahaan Plus Therapeutics|Likuiditas cepet plustherapeutics.com
- statistik bathi lan rasio pasar:
PSTV - Bathi sawise pajeg|Proyeksi bathi mangsa ngarep Plus Therapeutics, Inc.|PSTV - Kapitalisasi marang bathi|Prakiraan rega marang bathi Cytori Therapeutics|PSTV - Pangali PEG|Rasio nilai perusahaan marang bathi sadurunge bunga, pajeg, lan panyusutan Plus Therapeutics|PSTV - Bathi perusahaan sadurunge pajak, bunga, lan amortisasi|Bathi resik saben saham (EPS TTM) Plus Therapeutics|PSTV - Bathi resik saben saham sajrone patang kuartal pungkasan|Wutah bathi EPS kuartalan plustherapeutics.com|PSTV - Wutah bathi resik saben saham ing taun iki|Prakiraan wutah bathi resik saben saham kanggo taun ngarep Plus Therapeutics, Inc.
- indikator dodolan lan pendapatan:
PSTV - Pendapatan reged perusahaan|Volume dodolan mangsa ngarep perusahaan plustherapeutics.com|PSTV - Rasio kapitalisasi pasar marang pendapatan|Multiplikator Forward P/S PSTV|PSTV - Wutah pendapatan taunan sajrone rolas wulan kepungkur|Wutah pendapatan kuartal marang kuartal Plus Therapeutics|PSTV - Rasio nilai perusahaan marang pendapatan
- rincian tingkat margin:
Analisis fundamental perusahaan:PSTV, Plus Therapeutics Inc

Investors evaluate operational efficiency by analyzing the share of operating profit relative to total EBITDA. For Plus Therapeutics, Inc. (PSTV), whose radiopharmaceuticals are currently in clinical trials without a stable cash flow, the operating profit margin reflects high project development costs and a lack of self-sustaining cash.